Dow Up 0.09% Nasdaq Down 0.02%

XOMA Corporation (XOMA)

-NasdaqGM
4.32 Down 0.08(1.82%) 4:00PM EDT
Prev Close:4.40
Open:4.43
Bid:4.11 x 900
Ask:N/A
1y Target Est:9.00
Beta:2.66
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.27 - 4.43
52wk Range:3.42 - 9.57
Volume:890,706
Avg Vol (3m):1,339,060
Market Cap:462.57M
P/E (ttm):N/A
EPS (ttm):-1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 1.82%462.57M
NVSUp 0.32%218.36B
REGNDown 1.14%35.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback